Plasma xanthine oxidoreductase (XOR) activity in patients who require cardiovascular intensive care.
Shibata Y, Shirakabe A, Okazaki H, Matsushita M, Goda H, Shigihara S, Asano K, Kiuchi K, Tani K, Murase T, Nakamura T, Kobayashi N, Hata N, Asai K, Shimizu W.
Shibata Y, et al. Among authors: shimizu w.
Heart Vessels. 2020 Oct;35(10):1390-1400. doi: 10.1007/s00380-020-01608-x. Epub 2020 Apr 27.
Heart Vessels. 2020.
PMID: 32342210